Accel-Heal Technologies Limited was established in 2020 by a team of specialists with over 130 years’ combined experience. Each member of the team is passionate about what they do and together, they work to develop and deliver products that help to transform the lives of patients with painful and hard-to-heal wounds.
Meet the people behind Accel-Heal.
CHIEF EXECUTIVE OFFICER
Andy has enjoyed a successful 32-year career at Smith & Nephew. During his time at the FTSE 100 medical technology business, Andy engaged in developing, manufacturing, marketing and selling medical devices in the Advanced Wound Management and Advanced Surgical Devices sectors. He has held a number of executive level roles across commercial, strategic and innovation functions. Andy is passionate about the wound care sector and helping to improve the lives of patients suffering with debilitating complex wounds and since leaving Smith & Nephew has provided Board level support and strategic direction in the sector.
ANDREW WILDMAN ACA
CHIEF FINANCIAL OFFICER
Andrew has over 25 years’ experience working in and advising start-up and early stage businesses from inception through to exit. Andrew brings experience of managing businesses through the growth phase, determining corporate strategy and development, establishing strong corporate governance and preparing businesses for a successful exit. A Chartered Accountant since 1994, Andrew cut his teeth at Deloitte and Ernst & Young. Andrew has seen first-hand the damage that non-healing wounds does to people and is fanatical about raising the profile of this silent epidemic and improving healing rates.
Paul has over 25 years’ experience in wound management sales and marketing. He was previously responsible for leading global and regional marketing teams at Smith & Nephew, the FTSE 100 medical technology business. In the last 10 years he has been focussed on launching new technologies to health care professionals to help reduce complexity of wound care and improve access to more effective products. He maintains a fervent desire to support easier adoption of medical devices by health care practitioners to help them and their patients improve their outcomes.
Jessica has over 10 years’ experience as a regulatory professional, with a strong track record of success, overseeing the manufacturing, operations and regulatory compliance areas of the business. Jessica also plays an active role in a number of Supplier Work Groups, hosted by the Association of British HealthTech Industries.
NATIONAL KEY ACCOUNT MANAGER
Ed has over 15 years’ experience in the medical device and wound-care sales industry. Previous roles include commercial management, national sales and general management. Bringing this wide experience and combining it with his passion for wound care Ed’s vision is to build strong partnerships with NHS professionals to optimise wound healing and patient outcomes.
Clinical and Scientific Advisory Board Members
Dr Robin Martin
Dr Martin gained his B.Sc. in Biology from the University of Southampton and received his PhD in Genetics from the National Institute of Medical Research, Mill Hill, London in 1983. He joined Smith & Nephew Advanced Wound Management and held a variety of global Clinical & Scientific Affairs roles over 15 years' working on the development and clinical evidence for medical devices. In 2018 he established himself as an independent freelance Scientific Consultant working with clients across a wide range of Wound healing and Reconstructive Surgery topics. Dr Martin is the author/co-author of 63 papers, articles, books and patents.
DR LEANNE ATKIN
ADVISORY BOARD MEMBER
Dr Leanne Atkin is a Lecturer Practitioner at the University of Huddersfield, additionally being Vascular Nurse Consultant at Mid Yorks NHS Trust. Her passions include leg ulcer management, quality agenda, peripheral arterial disease and advanced wound management. She has published over 50 articles related to vascular diseases and wound management.
DR ARDESHIR BAYAT
ADVISORY BOARD MEMBER
Dr Ardeshir Bayat is a clinician scientist (reader) at the University of Manchester, UK and an honorary professor in the department of dermatology at the University of Cape Town in South Africa. His primary research focus is on wound healing and tissue repair. Using cutting edge experimental tools to gain a deeper insight into the molecular basis of healing.
DR JOHN POSNETT
ADVISORY BOARD MEMBER
As a health economist at PAREXEL Access Consulting, Dr John Posnett provides consultancy support to global pharmaceutical and medical device companies. John has held the roles of Director of the MSc programme in Health Economics and Professor of Applied Health Economics at the University of York while operating as a visiting lecturer and researcher at the Universities of Wyoming, Wisconsin, Lehigh and Sydney. He then moved Smith and Nephew for 10 years' and was global vice president for health economics. John has published widely in the areas of economics and health economics.
DR Amelia Swift
ADVISORY BOARD MEMBER
Amelia is a Senior Lecturer in Nursing with a long held interest in pain management. She completed her PhD in 2012. During this time she worked as a nurse researcher attached to a chronic pain team and explored the pain of epidermolysis bullosa. Over the past five years' Amelia has split her time between education and research. Amelia is passionate about pain education, research and evidence based practice and is the Chair of the British Pain Society Pain Education Special Interest Group and an Associate Editor of Evidence Based Practice.
Non Executive chairman
Reid, a New Zealand national, has over 25 years' in the Trust & Financial Services industry and works with HNWI clients on all facets of their wealth and estate planning requirements. He sits on the board of various companies with diversified investments and holdings and is himself an investor in private equity opportunities.
Non Executive Director
Christa has over 30 years' experience in Healthcare. Until 2003, she was CEO of a LSE listed company. Since then, she has worked as Chair for a number of Healthcare investment companies for a variety of Private Equity houses. She has also acted as NED on the Board of a LSE listed company. Her particular experience encompass specialist healthcare recruitment, childcare and education services, healthcare IT solutions, healthcare products, services and innovations.